NCT05781581

Brief Summary

To explore the relationship between SARS-CoV-2 infection in different time before operation and postoperative main complications (mortality, main pulmonary and cardiovascular complications) 30 days after operation; To determine the best timing of surgery after SARS-CoV-2 infection.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2023

Completed
7 days until next milestone

Study Start

First participant enrolled

March 19, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 23, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 23, 2023

Status Verified

March 1, 2023

Enrollment Period

6 months

First QC Date

March 12, 2023

Last Update Submit

March 12, 2023

Conditions

Intestines CancerPulmonary CancerLiver CancerTraumaFractures, BoneGynecologic Disease

Outcome Measures

Primary Outcomes (1)

  • All-cause mortality at 30 days after operation

    All-cause mortality at 30 days after operation

    30 days after surgery

Secondary Outcomes (2)

  • Main pulmonary complications at 30 days after operation

    30 days after surgery

  • Major Adverse Cardiovascular Events (MACE)

    30 days after surgery

Interventions

no interventionOTHER

no intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients having any type of surgery in operating room

You may qualify if:

  • Age≥18 years;
  • Patients undergoing any type of surgery in operating room.

You may not qualify if:

  • Surgery under local anesthesia (without participation of anesthetist)
  • Surgery outside the operating room, such as gastrointestinal endoscopy, puncture biopsy, etc
  • Patients who cannot determine whether they have had SARS CoV-2 infection before surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Intestinal NeoplasmsLung NeoplasmsLiver NeoplasmsWounds and InjuriesFractures, BoneGenital Diseases, Female

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesLiver DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Diansan Su, MD,PHD

    Renji Hospital, Shanghai Jiaotong University, School of Medcine

    STUDY CHAIR

Central Study Contacts

Diansan Su, MD,PHD

CONTACT

+8618616514088diansansu@yahoo.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2023

First Posted

March 23, 2023

Study Start

March 19, 2023

Primary Completion

August 31, 2023

Study Completion

December 31, 2024

Last Updated

March 23, 2023

Record last verified: 2023-03